Oxford Biomedica annual revenue
2020
2021
2022
2023
2024
2025
Oxford Biomedica reported £168.7M in revenue for fiscal 2025, an increase of 31.01% from the previous fiscal year.
View full Oxford Biomedica company overview| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | £168.7M | £39.9M | +31.01% |
| 2024 | 2024-12-31 | £128.8M | £39.3M | +43.84% |
| 2023 | 2023-12-31 | £89.5M | −£50.5M | −36.04% |
| 2022 | 2022-12-31 | £140.0M | −£2.8M | −1.97% |
| 2021 | 2021-12-31 | £142.8M | £55.1M | +62.77% |
| 2020 | 2020-12-31 | £87.7M | — | — |
Over the last five reported fiscal years, revenue grew from £87.7M to £168.7M, a compound annual growth rate of 13.98%.
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Oxford Biomedica source filings ↗